JoVE
JoVE
Faculty Resource Center
Research
Behavior
Biochemistry
Biology
Bioengineering
Cancer Research
Chemistry
Developmental Biology
Engineering
Environment
Genetics
Immunology and Infection
Medicine
Neuroscience
JoVE Journal
JoVE Encyclopedia of Experiments
JoVE Chrome Extension
Education
Biology
Chemistry
Clinical
Engineering
Environmental Sciences
Pharmacology
Physics
Psychology
Statistics
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Business
Videos Mapped to your Course
Authors
Librarians
High Schools
About
Sign-In
Sign In
Contact Us
Research
JoVE Journal
JoVE Encyclopedia of Experiments
Education
JoVE Core
JoVE Science Education
JoVE Lab Manual
High Schools
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Close
Research
Behavior
Biochemistry
Bioengineering
Biology
Cancer Research
Chemistry
Developmental Biology
Engineering
Environment
Genetics
Immunology and Infection
Medicine
Neuroscience
Products
JoVE Journal
JoVE Encyclopedia of Experiments
Education
Biology
Chemistry
Clinical
Engineering
Environmental Sciences
Pharmacology
Physics
Psychology
Statistics
Products
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Business
Videos Mapped to Your Course
Teacher Resources
Get in Touch
Instant Trial
Log In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Journal
/
Cancer Research
/
寻找获得性抗靶治疗的驱动途径: 耐药亚克隆生成与基因击倒敏感性恢复
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.
Sign in or start your free trial.
JoVE Journal
Cancer Research
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Please note that all translations are automatically generated.
Click here for the English version.
寻找获得性抗靶治疗的驱动途径: 耐药亚克隆生成与基因击倒敏感性恢复
DOI:
10.3791/56583-v
•
08:59 min
•
December 11, 2017
•
Chiara Arienti
,
Sara Pignatta
,
Michele Zanoni
,
Michela Cortesi
,
Alice Zamagni
,
Filippo Piccinini
,
Anna Tesei
1
Biosciences Laboratory
,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS
,
2
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS
Chapters
00:05
Title
01:39
Generation of Targeted Therapy Resistant Subclones
04:03
Restoring Target-therapy Inhibitor Sensitivity by Candidate R-gene Knock-down
06:31
Results: Drug Resistant Subclone Generation and Sensitivity Restoration
08:01
Conclusion
Summary
Automatic Translation
English (Original)
العربية (Arabic)
中文 (Chinese)
Nederlands (Dutch)
français (French)
Deutsch (German)
עברית (Hebrew)
italiano (Italian)
日本語 (Japanese)
한국어 (Korean)
português (Portuguese)
русский (Russian)
español (Spanish)
Türkçe (Turkish)
Automatic Translation
这是一个时间和经济高效的
体外
协议, 研究对靶向治疗剂的后天抗性机制, 这是癌症管理中极不满足的医疗需求。
Tags
– Acquired Resistance- Targeted Therapy- Drug Resistant Subclone- Sensitivity Restoration- Gene Knock-down- Tumor Heterogeneity- Mechanism Of Resistance- Preclinical Platform- Trastuzumab- HER-positive Gastric Cancer- In-vitro Drug Resistant Model- Gradually Increasing Drug Dose- Plasma Peak Concentration
Article
Embed
ADD TO PLAYLIST
Usage Statistics
Related Videos
利用RNA测序来检测新剪接变异体在相关耐药<em>体外</em>癌症模型
光动力疗法的抗癌功效肺癌靶向纳米粒子
抗有丝分裂药物多西紫杉醇的前列腺癌细胞模型的建立
高通量三维肿瘤球体药物筛选的生成
用抗体阵列对信号转导通路的审问对酪氨酸激酶抑制剂的抗性评价
使用锚定多路聚合酶链反应的致癌基因融合检测,随后进行下一代测序
利用人类诱导多能干细胞生成肿瘤抗原特异性T细胞
研究利普托梅宁格疾病直接靶向治疗的穆林·奥马亚异种格拉夫特模型
患者源性肿瘤外植体作为预测患者耐药性的"实时"临床前平台
组织中蛋白质和RNA表达的空间分析:一种微调虚拟显微切割的方法
Read Article